{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T04:11:45Z","timestamp":1789013505562,"version":"build-2803163510"},"reference-count":110,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"vor","delay-in-days":69,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"CHOP Research Institute"},{"DOI":"10.13039\/100000051","name":"National Human Genome Research Institute","doi-asserted-by":"publisher","award":["T32 HG000046"],"award-info":[{"award-number":["T32 HG000046"]}],"id":[{"id":"10.13039\/100000051","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000051","name":"National Human Genome Research Institute","doi-asserted-by":"publisher","award":["T32 HG000046"],"award-info":[{"award-number":["T32 HG000046"]}],"id":[{"id":"10.13039\/100000051","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["F31 NS122297"],"award-info":[{"award-number":["F31 NS122297"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001671","name":"Hereditary Disease Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001671","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurodegeneration"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Huntington\u2019s disease (HD) involves progressive corticostriatal dysfunction, yet the temporal dynamics and cell type-specific vulnerability patterns remain incompletely understood. While recent single-cell studies in rapidly progressing models have revealed early developmental and regional changes, temporal profiling distinguishing pathogenic mechanisms from normal aging in full-length HTT models remains lacking. Resolving stage-specific temporal dynamics across interconnected striatal and cortical neuronal populations over protracted time is essential for identifying drivers of cellular dysfunction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A temporal single-nucleus transcriptomic atlas was generated from striatum and motor cortex from heterozygous zQ175 knock-in mice at early symptomatic (6 months) and late symptomatic (18 months) stages. This full-length huntingtin model enables staging of progressive circuit dysfunction alongside physiological aging. The high inherited CAG repeat length of the zQ175 model places cells beyond the somatic expansion threshold associated with transcriptional dysregulation and identity erosion in vulnerable human neuronal populations, yet prior to the de-repression crisis and cell loss observed at the most extreme expansions in HD, providing a tractable window into the progressive molecular pathogenic cascade. Genotype-dependent effects were modeled to distinguish cell type-specific signatures of disease mechanisms from age-related and compensatory changes. Integration of weighted gene co-expression and transcription factor regulatory networks with protein-protein interaction databases predicted candidate regulators of stage-specific programs. Findings were validated across human HD datasets and the rapidly progressive R6\/2 mouse model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Temporal gene and network analysis revealed diverging, converging and biphasic patterns of transcriptional changes, distinguishing progressive disease and neuronal identity loss from aging. 21 cell type-specific gene co-expression modules were validated in human HD and R6\/2 mice datasets, revealing stage-specific shifts in cellular stress, proteostasis, and synaptic programs. Disease modules enriched for CAG repeat length-dependent genes resolved their temporal progression. Shared vulnerability across cortical and striatal projection neurons implicated epigenetic regulator Zswim6 and splicing factors Rbfox1 and Celf2 in corticostriatal dysfunction. Integrative network analysis identified Foxo1, Neurod2, and Npas2 as stage-specific transcriptional regulators. Cross-species validation established conserved gene regulatory modules in human HD, establishing generalizable cell type-specific gene modules of translational relevance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This temporally resolved atlas reveals stage-specific transcriptional dynamics of disease-relevant gene expression programs and physiological trajectories in vulnerable neuronal populations. distinguished from aging alone. This work establishes an important framework for understanding the temporal and regional coordination of pathogenic mechanisms, providing molecular insights into stage-specific therapeutic intervention.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13024-026-00960-2","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T13:14:30Z","timestamp":1779974070000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Temporal single-cell atlas of full-length Huntington\u2019s disease mouse model defines stage-specific signatures of corticostriatal dysfunction"],"prefix":"10.1186","volume":"21","author":[{"given":"Ashley B.","family":"Robbins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul T.","family":"Ranum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Icnelia","family":"Huerta-Ocampo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Kuckyr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beverly L.","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,28]]},"reference":[{"issue":"6","key":"960_CR1","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"A novel gene","year":"1993","unstructured":"A novel gene. containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. The Huntington\u2019s Disease Collaborative Research Group. Cell. 1993;72(6):971\u201383.","journal-title":"Cell"},{"issue":"6","key":"960_CR2","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","volume":"44","author":"JP Vonsattel","year":"1985","unstructured":"Vonsattel JP, Myers RH, Stevens TJ, Ferrante RJ, Bird ED, Richardson EP. Jr. Neuropathological classification of Huntington\u2019s disease. J Neuropathol Exp Neurol. 1985;44(6):559\u201377.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"17","key":"960_CR3","doi-asserted-by":"publisher","first-page":"5523","DOI":"10.1523\/JNEUROSCI.16-17-05523.1996","volume":"16","author":"PG Bhide","year":"1996","unstructured":"Bhide PG, Day M, Sapp E, Schwarz C, Sheth A, Kim J, et al. Expression of normal and mutant huntingtin in the developing brain. J Neurosci. 1996;16(17):5523\u201335.","journal-title":"J Neurosci"},{"key":"960_CR4","doi-asserted-by":"crossref","unstructured":"Li SH, Schilling G, Young WS 3rd, Li XJ, Margolis RL, Stine OC, et al. Huntington\u2019s disease gene (IT15) is widely expressed in human and rat tissues. Neuron. 1993;11(5):985\u201393.","DOI":"10.1016\/0896-6273(93)90127-D"},{"issue":"1","key":"960_CR5","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","volume":"10","author":"CA Ross","year":"2011","unstructured":"Ross CA, Tabrizi SJ. Huntington\u2019s disease: from molecular pathogenesis to clinical treatment. Lancet Neurol. 2011;10(1):83\u201398.","journal-title":"Lancet Neurol"},{"issue":"3","key":"960_CR6","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1089\/brain.2017.0538","volume":"8","author":"FA Espinoza","year":"2018","unstructured":"Espinoza FA, Turner JA, Vergara VM, Miller RL, Mennigen E, Liu J, et al. Whole-Brain Connectivity in a Large Study of Huntington\u2019s Disease Gene Mutation Carriers and Healthy Controls. Brain Connect. 2018;8(3):166\u201378.","journal-title":"Brain Connect"},{"issue":"2","key":"960_CR7","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.neulet.2012.02.095","volume":"514","author":"PG Unschuld","year":"2012","unstructured":"Unschuld PG, Joel SE, Liu X, Shanahan M, Margolis RL, Biglan KM, et al. Impaired cortico-striatal functional connectivity in prodromal Huntington\u2019s Disease. Neurosci Lett. 2012;514(2):204\u20139.","journal-title":"Neurosci Lett"},{"key":"960_CR8","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.nbd.2014.12.009","volume":"74","author":"GR Poudel","year":"2015","unstructured":"Poudel GR, Stout JC, Dominguez DJ, Churchyard A, Chua P, Egan GF, et al. Longitudinal change in white matter microstructure in Huntington\u2019s disease: The IMAGE-HD study. Neurobiol Dis. 2015;74:406\u201312.","journal-title":"Neurobiol Dis"},{"issue":"1","key":"960_CR9","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S1474-4422(10)70276-3","volume":"10","author":"SJ Tabrizi","year":"2011","unstructured":"Tabrizi SJ, Scahill RI, Durr A, Roos RA, Leavitt BR, Jones R, et al. Biological and clinical changes in premanifest and early stage Huntington\u2019s disease in the TRACK-HD study: the 12-month longitudinal analysis. Lancet Neurol. 2011;10(1):31\u201342.","journal-title":"Lancet Neurol"},{"issue":"3","key":"960_CR10","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.cell.2024.11.038","volume":"188","author":"RE Handsaker","year":"2025","unstructured":"Handsaker RE, Kashin S, Reed NM, Tan S, Lee WS, McDonald TM, et al. Long somatic DNA-repeat expansion drives neurodegeneration in Huntington\u2019s disease. Cell. 2025;188(3):623\u201339. e19.","journal-title":"Cell"},{"key":"960_CR11","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/B978-0-444-52014-2.00004-5","volume":"100","author":"JP Vonsattel","year":"2011","unstructured":"Vonsattel JP, Keller C, Cortes Ramirez EP. Huntington\u2019s disease - neuropathology. Handb Clin Neurol. 2011;100:83\u2013100.","journal-title":"Handb Clin Neurol"},{"issue":"1","key":"960_CR12","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1212\/01.WNL.0000132965.14653.D1","volume":"63","author":"EH Aylward","year":"2004","unstructured":"Aylward EH, Sparks BF, Field KM, Yallapragada V, Shpritz BD, Rosenblatt A, et al. Onset and rate of striatal atrophy in preclinical Huntington disease. Neurology. 2004;63(1):66\u201372.","journal-title":"Neurology"},{"issue":"1","key":"960_CR13","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.biopsych.2005.06.003","volume":"59","author":"JS Paulsen","year":"2006","unstructured":"Paulsen JS, Magnotta VA, Mikos AE, Paulson HL, Penziner E, Andreasen NC, et al. Brain structure in preclinical Huntington\u2019s disease. Biol Psychiatry. 2006;59(1):57\u201363.","journal-title":"Biol Psychiatry"},{"issue":"1","key":"960_CR14","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1136\/jnnp-2020-324377","volume":"92","author":"C Estevez-Fraga","year":"2020","unstructured":"Estevez-Fraga C, Scahill R, Rees G, Tabrizi SJ, Gregory S. Diffusion imaging in Huntington\u2019s disease: comprehensive review. J Neurol Neurosurg Psychiatry. 2020;92(1):62\u20139.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"960_CR15","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1093\/brain\/awab367","volume":"145","author":"A Nair","year":"2022","unstructured":"Nair A, Razi A, Gregory S, Rutledge RB, Rees G, Tabrizi SJ. Imbalanced basal ganglia connectivity is associated with motor deficits and apathy in Huntington\u2019s disease. Brain. 2022;145(3):991\u20131000.","journal-title":"Brain"},{"key":"960_CR16","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.conb.2015.05.002","volume":"33","author":"G Silberberg","year":"2015","unstructured":"Silberberg G, Bolam JP. Local and afferent synaptic pathways in the striatal microcircuitry. Curr Opin Neurobiol. 2015;33:182\u20137.","journal-title":"Curr Opin Neurobiol"},{"issue":"15","key":"960_CR17","doi-asserted-by":"publisher","first-page":"5733","DOI":"10.1073\/pnas.85.15.5733","volume":"85","author":"A Reiner","year":"1988","unstructured":"Reiner A, Albin RL, Anderson KD, D\u2019Amato CJ, Penney JB, Young AB. Differential loss of striatal projection neurons in Huntington disease. Proc Natl Acad Sci U S A. 1988;85(15):5733\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"960_CR18","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.jchemneu.2004.02.005","volume":"27","author":"YP Deng","year":"2004","unstructured":"Deng YP, Albin RL, Penney JB, Young AB, Anderson KD, Reiner A. Differential loss of striatal projection systems in Huntington\u2019s disease: a quantitative immunohistochemical study. J Chem Neuroanat. 2004;27(3):143\u201364.","journal-title":"J Chem Neuroanat"},{"key":"960_CR19","doi-asserted-by":"crossref","unstructured":"Morigaki R, Yoshida T, Fujikawa J, Crittenden JR, Graybiel AM. Molecular imbalances between striosome and matrix compartments characterize the pathogenesis and pathophysiology of Huntington\u2019s disease model mouse. Int J Mol Sci. 2025;26(17):8342.","DOI":"10.3390\/ijms26178573"},{"issue":"1","key":"960_CR20","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/s41467-022-35752-x","volume":"14","author":"A Matsushima","year":"2023","unstructured":"Matsushima A, Pineda SS, Crittenden JR, Lee H, Galani K, Mantero J, et al. Transcriptional vulnerabilities of striatal neurons in human and rodent models of Huntington\u2019s disease. Nat Commun. 2023;14(1):282.","journal-title":"Nat Commun"},{"issue":"5","key":"960_CR21","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1093\/jnen\/nlae022","volume":"83","author":"JC Hedreen","year":"2024","unstructured":"Hedreen JC, Berretta S, White Iii CL. Postmortem neuropathology in early Huntington disease. J Neuropathol Exp Neurol. 2024;83(5):294\u2013306.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"6","key":"960_CR22","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/nn.3397","volume":"16","author":"GJ Kress","year":"2013","unstructured":"Kress GJ, Yamawaki N, Wokosin DL, Wickersham IR, Shepherd GM, Surmeier DJ. Convergent cortical innervation of striatal projection neurons. Nat Neurosci. 2013;16(6):665\u20137.","journal-title":"Nat Neurosci"},{"issue":"11","key":"960_CR23","doi-asserted-by":"publisher","first-page":"4112","DOI":"10.1002\/hbm.23299","volume":"37","author":"F Gargouri","year":"2016","unstructured":"Gargouri F, Messe A, Perlbarg V, Valabregue R, McColgan P, Yahia-Cherif L, et al. Longitudinal changes in functional connectivity of cortico-basal ganglia networks in manifests and premanifest huntington\u2019s disease. Hum Brain Mapp. 2016;37(11):4112\u201328.","journal-title":"Hum Brain Mapp"},{"issue":"5","key":"960_CR24","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1002\/ana.410120504","volume":"12","author":"DE Kuhl","year":"1982","unstructured":"Kuhl DE, Phelps ME, Markham CH, Metter EJ, Riege WH, Winter J. Cerebral metabolism and atrophy in Huntington\u2019s disease determined by 18FDG and computed tomographic scan. Ann Neurol. 1982;12(5):425\u201334.","journal-title":"Ann Neurol"},{"issue":"1","key":"960_CR25","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1002\/mdc3.12866","volume":"7","author":"S Gregory","year":"2020","unstructured":"Gregory S, Johnson E, Byrne LM, Rodrigues FB, Henderson A, Moss J, et al. Characterizing White Matter in Huntington\u2019s Disease. Mov Disord Clin Pract. 2020;7(1):52\u201360.","journal-title":"Mov Disord Clin Pract"},{"issue":"3","key":"960_CR26","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1006\/nbdi.2002.0528","volume":"10","author":"V Macdonald","year":"2002","unstructured":"Macdonald V, Halliday G. Pyramidal cell loss in motor cortices in Huntington\u2019s disease. Neurobiol Dis. 2002;10(3):378\u201386.","journal-title":"Neurobiol Dis"},{"issue":"2","key":"960_CR27","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/0304-3940(91)90583-F","volume":"133","author":"JC Hedreen","year":"1991","unstructured":"Hedreen JC, Peyser CE, Folstein SE, Ross CA. Neuronal loss in layers V and VI of cerebral cortex in Huntington\u2019s disease. Neurosci Lett. 1991;133(2):257\u201361.","journal-title":"Neurosci Lett"},{"issue":"Pt 4","key":"960_CR28","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1093\/brain\/awq047","volume":"133","author":"DC Thu","year":"2010","unstructured":"Thu DC, Oorschot DE, Tippett LJ, Nana AL, Hogg VM, Synek BJ, et al. Cell loss in the motor and cingulate cortex correlates with symptomatology in Huntington\u2019s disease. Brain. 2010;133(Pt 4):1094\u2013110.","journal-title":"Brain"},{"key":"960_CR29","doi-asserted-by":"crossref","unstructured":"Pressl C, Matlik K, Kus L, Darnell P, Luo JD, Paul MR, et al. Selective vulnerability of layer 5a corticostriatal neurons in Huntington\u2019s disease. bioRxiv. 2023.","DOI":"10.2139\/ssrn.4486500"},{"issue":"5","key":"960_CR30","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.neuron.2020.06.021","volume":"107","author":"H Lee","year":"2020","unstructured":"Lee H, Fenster RJ, Pineda SS, Gibbs WS, Mohammadi S, Davila-Velderrain J, et al. Cell Type-Specific Transcriptomics Reveals that Mutant Huntingtin Leads to Mitochondrial RNA Release and Neuronal Innate Immune Activation. Neuron. 2020;107(5):891\u2013908. e8.","journal-title":"Neuron"},{"key":"960_CR31","doi-asserted-by":"crossref","unstructured":"Paryani F, Kwon JS, Ng CW, Madden N, Ofori K, Tang A, et al. Multi-OMIC analysis of Huntington disease reveals a neuroprotective astrocyte state. bioRxiv. 2023.","DOI":"10.1101\/2023.09.08.556867"},{"issue":"7879","key":"960_CR32","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/s41586-021-03500-8","volume":"598","author":"Z Yao","year":"2021","unstructured":"Yao Z, Liu H, Xie F, Fischer S, Adkins RS, Aldridge AI, et al. A transcriptomic and epigenomic cell atlas of the mouse primary motor cortex. Nature. 2021;598(7879):103\u201310.","journal-title":"Nature"},{"issue":"25","key":"960_CR33","doi-asserted-by":"publisher","first-page":"5534","DOI":"10.1523\/JNEUROSCI.2074-20.2021","volume":"41","author":"S Malaiya","year":"2021","unstructured":"Malaiya S, Cortes-Gutierrez M, Herb BR, Coffey SR, Legg SRW, Cantle JP, et al. Single-Nucleus RNA-Seq Reveals Dysregulation of Striatal Cell Identity Due to Huntington\u2019s Disease Mutations. J Neurosci. 2021;41(25):5534\u201352.","journal-title":"J Neurosci"},{"issue":"1","key":"960_CR34","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40478-020-0880-6","volume":"8","author":"O Al-Dalahmah","year":"2020","unstructured":"Al-Dalahmah O, Sosunov AA, Shaik A, Ofori K, Liu Y, Vonsattel JP, et al. Single-nucleus RNA-seq identifies Huntington disease astrocyte states. Acta Neuropathol Commun. 2020;8(1):19.","journal-title":"Acta Neuropathol Commun"},{"key":"960_CR35","doi-asserted-by":"crossref","unstructured":"Burns MS, Miramontes R, Wu J, Gulia R, Saddala MS, Lau AL, et al. Distinct molecular patterns in R6\/2 HD mouse brain: insights from spatiotemporal transcriptomics. Neuron. 2025.","DOI":"10.1016\/j.neuron.2025.05.014"},{"issue":"12","key":"960_CR36","doi-asserted-by":"publisher","first-page":"e49838","DOI":"10.1371\/journal.pone.0049838","volume":"7","author":"LB Menalled","year":"2012","unstructured":"Menalled LB, Kudwa AE, Miller S, Fitzpatrick J, Watson-Johnson J, Keating N, et al. Comprehensive behavioral and molecular characterization of a new knock-in mouse model of Huntington\u2019s disease: zQ175. PLoS ONE. 2012;7(12):e49838.","journal-title":"PLoS ONE"},{"issue":"1","key":"960_CR37","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/cne.10776","volume":"465","author":"LB Menalled","year":"2003","unstructured":"Menalled LB, Sison JD, Dragatsis I, Zeitlin S, Chesselet MF. Time course of early motor and neuropathological anomalies in a knock-in mouse model of Huntington\u2019s disease with 140 CAG repeats. J Comp Neurol. 2003;465(1):11\u201326.","journal-title":"J Comp Neurol"},{"issue":"1","key":"960_CR38","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3233\/JHD-210515","volume":"11","author":"S St-Cyr","year":"2022","unstructured":"St-Cyr S, Smith AR, Davidson BL. Temporal Phenotypic Changes in Huntington\u2019s Disease Models for Preclinical Studies. J Huntingtons Dis. 2022;11(1):35\u201357.","journal-title":"J Huntingtons Dis"},{"issue":"12","key":"960_CR39","doi-asserted-by":"publisher","first-page":"e50717","DOI":"10.1371\/journal.pone.0050717","volume":"7","author":"T Heikkinen","year":"2012","unstructured":"Heikkinen T, Lehtimaki K, Vartiainen N, Puolivali J, Hendricks SJ, Glaser JR, et al. Characterization of neurophysiological and behavioral changes, MRI brain volumetry and 1H MRS in zQ175 knock-in mouse model of Huntington\u2019s disease. PLoS ONE. 2012;7(12):e50717.","journal-title":"PLoS ONE"},{"issue":"3","key":"960_CR40","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/s41588-024-01653-6","volume":"56","author":"K Matlik","year":"2024","unstructured":"Matlik K, Baffuto M, Kus L, Deshmukh AL, Davis DA, Paul MR, et al. Cell-type-specific CAG repeat expansions and toxicity of mutant Huntingtin in human striatum and cerebellum. Nat Genet. 2024;56(3):383\u201394.","journal-title":"Nat Genet"},{"issue":"6385","key":"960_CR41","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1126\/science.aam8999","volume":"360","author":"AB Rosenberg","year":"2018","unstructured":"Rosenberg AB, Roco CM, Muscat RA, Kuchina A, Sample P, Yao Z, et al. Single-cell profiling of the developing mouse brain and spinal cord with split-pool barcoding. Science. 2018;360(6385):176\u201382.","journal-title":"Science"},{"issue":"7","key":"960_CR42","doi-asserted-by":"publisher","first-page":"2953","DOI":"10.1152\/jn.01056.2014","volume":"113","author":"T Indersmitten","year":"2015","unstructured":"Indersmitten T, Tran CH, Cepeda C, Levine MS. Altered excitatory and inhibitory inputs to striatal medium-sized spiny neurons and cortical pyramidal neurons in the Q175 mouse model of Huntington\u2019s disease. J Neurophysiol. 2015;113(7):2953\u201366.","journal-title":"J Neurophysiol"},{"issue":"6","key":"960_CR43","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1016\/j.neuron.2016.10.064","volume":"92","author":"V Beaumont","year":"2016","unstructured":"Beaumont V, Zhong S, Lin H, Xu W, Bradaia A, Steidl E, et al. Phosphodiesterase 10A Inhibition Improves Cortico-Basal Ganglia Function in Huntington\u2019s Disease Models. Neuron. 2016;92(6):1220\u201337.","journal-title":"Neuron"},{"key":"960_CR44","doi-asserted-by":"crossref","unstructured":"Wang Y, Ramandi D, Sepers MD, Mackay JP, Raymond LA. Age- and region-dependent cortical excitability in the zQ175 Huntington disease mouse model. Hum Mol Genet. 2023.","DOI":"10.1093\/hmg\/ddad191"},{"issue":"17","key":"960_CR45","doi-asserted-by":"publisher","first-page":"4510","DOI":"10.1093\/hmg\/ddu166","volume":"23","author":"GA Smith","year":"2014","unstructured":"Smith GA, Rocha EM, McLean JR, Hayes MA, Izen SC, Isacson O, et al. Progressive axonal transport and synaptic protein changes correlate with behavioral and neuropathological abnormalities in the heterozygous Q175 KI mouse model of Huntington\u2019s disease. Hum Mol Genet. 2014;23(17):4510\u201327.","journal-title":"Hum Mol Genet"},{"issue":"4","key":"960_CR46","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/nn.4256","volume":"19","author":"P Langfelder","year":"2016","unstructured":"Langfelder P, Cantle JP, Chatzopoulou D, Wang N, Gao F, Al-Ramahi I, et al. Integrated genomics and proteomics define huntingtin CAG length-dependent networks in mice. Nat Neurosci. 2016;19(4):623\u201333.","journal-title":"Nat Neurosci"},{"issue":"7991","key":"960_CR47","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/s41586-023-06812-z","volume":"624","author":"Z Yao","year":"2023","unstructured":"Yao Z, van Velthoven CTJ, Kunst M, Zhang M, McMillen D, Lee C, et al. A high-resolution transcriptomic and spatial atlas of cell types in the whole mouse brain. Nature. 2023;624(7991):317\u201332.","journal-title":"Nature"},{"key":"960_CR48","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1186\/s13059-015-0844-5","volume":"16","author":"G Finak","year":"2015","unstructured":"Finak G, McDavid A, Yajima M, Deng J, Gersuk V, Shalek AK, et al. MAST: a flexible statistical framework for assessing transcriptional changes and characterizing heterogeneity in single-cell RNA sequencing data. Genome Biol. 2015;16:278.","journal-title":"Genome Biol"},{"issue":"1","key":"960_CR49","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26(1):139\u201340.","journal-title":"Bioinformatics"},{"issue":"21","key":"960_CR50","doi-asserted-by":"publisher","first-page":"3378","DOI":"10.1016\/j.neuron.2023.08.004","volume":"111","author":"Z Farsi","year":"2023","unstructured":"Farsi Z, Nicolella A, Simmons SK, Aryal S, Shepard N, Brenner K, et al. Brain-region-specific changes in neurons and glia and dysregulation of dopamine signaling in Grin2a mutant mice. Neuron. 2023;111(21):3378\u2013e969.","journal-title":"Neuron"},{"issue":"20","key":"960_CR51","doi-asserted-by":"publisher","first-page":"4438","DOI":"10.1016\/j.cell.2023.08.005","volume":"186","author":"V Gazestani","year":"2023","unstructured":"Gazestani V, Kamath T, Nadaf NM, Dougalis A, Burris SJ, Rooney B, et al. Early Alzheimer\u2019s disease pathology in human cortex involves transient cell states. Cell. 2023;186(20):4438\u2013e5323.","journal-title":"Cell"},{"issue":"6","key":"960_CR52","doi-asserted-by":"publisher","first-page":"100498","DOI":"10.1016\/j.crmeth.2023.100498","volume":"3","author":"S Morabito","year":"2023","unstructured":"Morabito S, Reese F, Rahimzadeh N, Miyoshi E, Swarup V. hdWGCNA identifies co-expression networks in high-dimensional transcriptomics data. Cell Rep Methods. 2023;3(6):100498.","journal-title":"Cell Rep Methods"},{"issue":"1","key":"960_CR53","doi-asserted-by":"publisher","first-page":"7791","DOI":"10.1038\/s41467-022-35388-x","volume":"13","author":"RG Lim","year":"2022","unstructured":"Lim RG, Al-Dalahmah O, Wu J, Gold MP, Reidling JC, Tang G, et al. Huntington disease oligodendrocyte maturation deficits revealed by single-nucleus RNAseq are rescued by thiamine-biotin supplementation. Nat Commun. 2022;13(1):7791.","journal-title":"Nat Commun"},{"issue":"7","key":"960_CR54","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1002\/cne.25023","volume":"529","author":"Y Deng","year":"2021","unstructured":"Deng Y, Wang H, Joni M, Sekhri R, Reiner A. Progression of basal ganglia pathology in heterozygous Q175 knock-in Huntington\u2019s disease mice. J Comp Neurol. 2021;529(7):1327\u201371.","journal-title":"J Comp Neurol"},{"issue":"7879","key":"960_CR55","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41586-021-03705-x","volume":"598","author":"M Zhang","year":"2021","unstructured":"Zhang M, Eichhorn SW, Zingg B, Yao Z, Cotter K, Zeng H, et al. Spatially resolved cell atlas of the mouse primary motor cortex by MERFISH. Nature. 2021;598(7879):137\u201343.","journal-title":"Nature"},{"issue":"1","key":"960_CR56","doi-asserted-by":"publisher","first-page":"5692","DOI":"10.1038\/s41467-021-25960-2","volume":"12","author":"JW Squair","year":"2021","unstructured":"Squair JW, Gautier M, Kathe C, Anderson MA, James ND, Hutson TH, et al. Confronting false discoveries in single-cell differential expression. Nat Commun. 2021;12(1):5692.","journal-title":"Nat Commun"},{"issue":"7","key":"960_CR57","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47.","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"960_CR58","doi-asserted-by":"publisher","first-page":"R29","DOI":"10.1186\/gb-2014-15-2-r29","volume":"15","author":"CW Law","year":"2014","unstructured":"Law CW, Chen Y, Shi W, Smyth GK. voom: Precision weights unlock linear model analysis tools for RNA-seq read counts. Genome Biol. 2014;15(2):R29.","journal-title":"Genome Biol"},{"issue":"15","key":"960_CR59","doi-asserted-by":"publisher","first-page":"e97","DOI":"10.1093\/nar\/gkv412","volume":"43","author":"R Liu","year":"2015","unstructured":"Liu R, Holik AZ, Su S, Jansz N, Chen K, Leong HS, et al. Why weight? Modelling sample and observational level variability improves power in RNA-seq analyses. Nucleic Acids Res. 2015;43(15):e97.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"960_CR60","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1124\/jpet.121.000735","volume":"379","author":"SH Li","year":"2021","unstructured":"Li SH, Colson TL, Abd-Elrahman KS, Ferguson SSG. Metabotropic Glutamate Receptor 2\/3 Activation Improves Motor Performance and Reduces Pathology in Heterozygous zQ175 Huntington Disease Mice. J Pharmacol Exp Ther. 2021;379(1):74\u201384.","journal-title":"J Pharmacol Exp Ther"},{"key":"960_CR61","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/2040-2392-5-31","volume":"5","author":"AR Gupta","year":"2014","unstructured":"Gupta AR, Pirruccello M, Cheng F, Kang HJ, Fernandez TV, Baskin JM, et al. Rare deleterious mutations of the gene EFR3A in autism spectrum disorders. Mol Autism. 2014;5:31.","journal-title":"Mol Autism"},{"issue":"5","key":"960_CR62","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1096\/fj.201601207R","volume":"31","author":"Q Qian","year":"2017","unstructured":"Qian Q, Liu Q, Zhou D, Pan H, Liu Z, He F, et al. Brain-specific ablation of Efr3a promotes adult hippocampal neurogenesis via the brain-derived neurotrophic factor pathway. FASEB J. 2017;31(5):2104\u201313.","journal-title":"FASEB J"},{"issue":"9","key":"960_CR63","doi-asserted-by":"publisher","first-page":"3051","DOI":"10.1016\/j.celrep.2020.02.030","volume":"30","author":"AG Anderson","year":"2020","unstructured":"Anderson AG, Kulkarni A, Harper M, Konopka G. Single-Cell Analysis of Foxp1-Driven Mechanisms Essential for Striatal Development. Cell Rep. 2020;30(9):3051\u201366. e7.","journal-title":"Cell Rep"},{"key":"960_CR64","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3389\/fcell.2016.00056","volume":"4","author":"KM Reyskens","year":"2016","unstructured":"Reyskens KM, Arthur JS. Emerging Roles of the Mitogen and Stress Activated Kinases MSK1 and MSK2. Front Cell Dev Biol. 2016;4:56.","journal-title":"Front Cell Dev Biol"},{"issue":"18","key":"960_CR65","doi-asserted-by":"publisher","first-page":"4324","DOI":"10.1523\/JNEUROSCI.5227-03.2004","volume":"24","author":"JS Arthur","year":"2004","unstructured":"Arthur JS, Fong AL, Dwyer JM, Davare M, Reese E, Obrietan K, et al. Mitogen- and stress-activated protein kinase 1 mediates cAMP response element-binding protein phosphorylation and activation by neurotrophins. J Neurosci. 2004;24(18):4324\u201332.","journal-title":"J Neurosci"},{"issue":"4","key":"960_CR66","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1096\/fj.07-9814","volume":"22","author":"E Roze","year":"2008","unstructured":"Roze E, Betuing S, Deyts C, Marcon E, Brami-Cherrier K, Pages C, et al. Mitogen- and stress-activated protein kinase-1 deficiency is involved in expanded-huntingtin-induced transcriptional dysregulation and striatal death. FASEB J. 2008;22(4):1083\u201393.","journal-title":"FASEB J"},{"issue":"12","key":"960_CR67","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1093\/hmg\/ddr148","volume":"20","author":"E Martin","year":"2011","unstructured":"Martin E, Betuing S, Pages C, Cambon K, Auregan G, Deglon N, et al. Mitogen- and stress-activated protein kinase 1-induced neuroprotection in Huntington\u2019s disease: role on chromatin remodeling at the PGC-1-alpha promoter. Hum Mol Genet. 2011;20(12):2422\u201334.","journal-title":"Hum Mol Genet"},{"issue":"6623","key":"960_CR68","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/386395a0","volume":"386","author":"DF Emerich","year":"1997","unstructured":"Emerich DF, Winn SR, Hantraye PM, Peschanski M, Chen EY, Chu Y, et al. Protective effect of encapsulated cells producing neurotrophic factor CNTF in a monkey model of Huntington\u2019s disease. Nature. 1997;386(6623):395\u20139.","journal-title":"Nature"},{"issue":"3","key":"960_CR69","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3727\/000000004783983981","volume":"13","author":"DF Emerich","year":"2004","unstructured":"Emerich DF, Winn SR. Neuroprotective effects of encapsulated CNTF-producing cells in a rodent model of Huntington\u2019s disease are dependent on the proximity of the implant to the lesioned striatum. Cell Transpl. 2004;13(3):253\u20139.","journal-title":"Cell Transpl"},{"issue":"3","key":"960_CR70","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1177\/096368979700600308","volume":"6","author":"DF Emerich","year":"1997","unstructured":"Emerich DF, Cain CK, Greco C, Saydoff JA, Hu ZY, Liu H, et al. Cellular delivery of human CNTF prevents motor and cognitive dysfunction in a rodent model of Huntington\u2019s disease. Cell Transpl. 1997;6(3):249\u201366.","journal-title":"Cell Transpl"},{"issue":"1","key":"960_CR71","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1242\/dev.118.1.283","volume":"118","author":"BA Barres","year":"1993","unstructured":"Barres BA, Schmid R, Sendnter M, Raff MC. Multiple extracellular signals are required for long-term oligodendrocyte survival. Development. 1993;118(1):283\u201395.","journal-title":"Development"},{"issue":"27","key":"960_CR72","doi-asserted-by":"publisher","first-page":"7094","DOI":"10.1523\/JNEUROSCI.0174-07.2007","volume":"27","author":"C Escartin","year":"2007","unstructured":"Escartin C, Pierre K, Colin A, Brouillet E, Delzescaux T, Guillermier M, et al. Activation of astrocytes by CNTF induces metabolic plasticity and increases resistance to metabolic insults. J Neurosci. 2007;27(27):7094\u2013104.","journal-title":"J Neurosci"},{"key":"960_CR73","doi-asserted-by":"crossref","unstructured":"Luis-Ravelo D, Fumagallo-Reading F, Febles-Casquero A, Lopez-Fernandez J, Marcellino DJ, Gonzalez-Hernandez T. Dopamine receptor D3 induces transient, mTORC1-dependent autophagy that becomes persistent, AMPK-mediated, and neuroprotective in experimental models of Huntington\u2019s disease. Cells. 2025;14(9):760.","DOI":"10.3390\/cells14090652"},{"issue":"8","key":"960_CR74","doi-asserted-by":"publisher","first-page":"eaaw2880","DOI":"10.1126\/sciadv.aaw2880","volume":"5","author":"IS Fetahu","year":"2019","unstructured":"Fetahu IS, Ma D, Rabidou K, Argueta C, Smith M, Liu H, et al. Epigenetic signatures of methylated DNA cytosine in Alzheimer\u2019s disease. Sci Adv. 2019;5(8):eaaw2880.","journal-title":"Sci Adv"},{"issue":"1","key":"960_CR75","doi-asserted-by":"publisher","first-page":"21163","DOI":"10.1038\/s41598-024-72096-6","volume":"14","author":"A Penning","year":"2024","unstructured":"Penning A, Snoeck S, Garritsen O, Tosoni G, Hof A, de Boer F, et al. NACC2, a molecular effector of miR-132 regulation at the interface between adult neurogenesis and Alzheimer\u2019s disease. Sci Rep. 2024;14(1):21163.","journal-title":"Sci Rep"},{"key":"960_CR76","doi-asserted-by":"crossref","unstructured":"Bocchi VD, Conforti P, Vezzoli E, Besusso D, Cappadona C, Lischetti T et al. The coding and long noncoding single-cell atlas of the developing human fetal striatum. Science. 2021;372(6542).","DOI":"10.1126\/science.abf5759"},{"issue":"32","key":"960_CR77","doi-asserted-by":"publisher","first-page":"E3017","DOI":"10.1073\/pnas.1220176110","volume":"110","author":"F Cimadamore","year":"2013","unstructured":"Cimadamore F, Amador-Arjona A, Chen C, Huang CT, Terskikh AV. SOX2-LIN28\/let-7 pathway regulates proliferation and neurogenesis in neural precursors. Proc Natl Acad Sci U S A. 2013;110(32):E3017\u201326.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"29","key":"960_CR78","doi-asserted-by":"publisher","first-page":"E3864","DOI":"10.1073\/pnas.1501077112","volume":"112","author":"EJ Golden","year":"2015","unstructured":"Golden EJ, Benito-Gonzalez A, Doetzlhofer A. The RNA-binding protein LIN28B regulates developmental timing in the mammalian cochlea. Proc Natl Acad Sci U S A. 2015;112(29):E3864\u201373.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"D1","key":"960_CR79","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk D, Kirsch R, Koutrouli M, Nastou K, Mehryary F, Hachilif R, et al. The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 2023;51(D1):D638\u201346.","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"960_CR80","doi-asserted-by":"publisher","first-page":"eadq6663","DOI":"10.1126\/sciadv.adq6663","volume":"11","author":"K Choi","year":"2025","unstructured":"Choi K, Henderson NT, Feierman ER, Louzon S, Galanaugh J, Davatolhagh F, et al. Control of striatal circuit development by the chromatin regulator Zswim6. Sci Adv. 2025;11(3):eadq6663.","journal-title":"Sci Adv"},{"issue":"7","key":"960_CR81","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1080\/15476286.2020.1809186","volume":"18","author":"S Prashad","year":"2021","unstructured":"Prashad S, Gopal PP. RNA-binding proteins in neurological development and disease. RNA Biol. 2021;18(7):972\u201387.","journal-title":"RNA Biol"},{"key":"960_CR82","doi-asserted-by":"crossref","unstructured":"Bill BR, Lowe JK, Dybuncio CT, Fogel BL. Orchestration of neurodevelopmental programs by RBFOX1: Elsevier; 2013. p. 251\u201367.","DOI":"10.1016\/B978-0-12-418700-9.00008-3"},{"issue":"10","key":"960_CR83","doi-asserted-by":"publisher","first-page":"109226","DOI":"10.1016\/j.celrep.2021.109226","volume":"35","author":"MJ MacPherson","year":"2021","unstructured":"MacPherson MJ, Erickson SL, Kopp D, Wen P, Aghanoori MR, Kedia S, et al. Nucleocytoplasmic transport of the RNA-binding protein CELF2 regulates neural stem cell fates. Cell Rep. 2021;35(10):109226.","journal-title":"Cell Rep"},{"issue":"9","key":"960_CR84","doi-asserted-by":"publisher","first-page":"3405","DOI":"10.1073\/pnas.0511316103","volume":"103","author":"BI Bae","year":"2006","unstructured":"Bae BI, Hara MR, Cascio MB, Wellington CL, Hayden MR, Ross CA, et al. Mutant huntingtin: nuclear translocation and cytotoxicity mediated by GAPDH. Proc Natl Acad Sci U S A. 2006;103(9):3405\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"960_CR85","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1038\/s41419-021-04432-x","volume":"12","author":"A Sonmez","year":"2021","unstructured":"Sonmez A, Mustafa R, Ryll ST, Tuorto F, Wacheul L, Ponti D, et al. Nucleolar stress controls mutant Huntington toxicity and monitors Huntington\u2019s disease progression. Cell Death Dis. 2021;12(12):1139.","journal-title":"Cell Death Dis"},{"issue":"2","key":"960_CR86","doi-asserted-by":"publisher","first-page":"fcae016","DOI":"10.1093\/braincomms\/fcae016","volume":"6","author":"EP Hong","year":"2024","unstructured":"Hong EP, Ramos EM, Aziz NA, Massey TH, McAllister B, Lobanov S, et al. Modification of Huntington\u2019s disease by short tandem repeats. Brain Commun. 2024;6(2):fcae016.","journal-title":"Brain Commun"},{"issue":"3","key":"960_CR87","doi-asserted-by":"publisher","first-page":"113956","DOI":"10.1016\/j.celrep.2024.113956","volume":"43","author":"JE Childs","year":"2024","unstructured":"Childs JE, Morabito S, Das S, Santelli C, Pham V, Kusche K, et al. Relapse to cocaine seeking is regulated by medial habenula NR4A2\/NURR1 in mice. Cell Rep. 2024;43(3):113956.","journal-title":"Cell Rep"},{"key":"960_CR88","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.mcn.2017.02.003","volume":"80","author":"RR Waclaw","year":"2017","unstructured":"Waclaw RR, Ehrman LA, Merchan-Sala P, Kohli V, Nardini D, Campbell K. Foxo1 is a downstream effector of Isl1 in direct pathway striatal projection neuron development within the embryonic mouse telencephalon. Mol Cell Neurosci. 2017;80:44\u201351.","journal-title":"Mol Cell Neurosci"},{"issue":"1","key":"960_CR89","doi-asserted-by":"publisher","first-page":"E168","DOI":"10.1073\/pnas.1319138111","volume":"111","author":"KM Lu","year":"2014","unstructured":"Lu KM, Evans SM, Hirano S, Liu FC. Dual role for Islet-1 in promoting striatonigral and repressing striatopallidal genetic programs to specify striatonigral cell identity. Proc Natl Acad Sci U S A. 2014;111(1):E168\u201377.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"960_CR90","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1101\/gad.1984311","volume":"25","author":"P Xu","year":"2011","unstructured":"Xu P, Das M, Reilly J, Davis RJ. JNK regulates FoxO-dependent autophagy in neurons. Genes Dev. 2011;25(4):310\u201322.","journal-title":"Genes Dev"},{"issue":"11","key":"960_CR91","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1093\/hmg\/ddab095","volume":"30","author":"GV Furtado","year":"2021","unstructured":"Furtado GV, Yang J, Wu D, Papagiannopoulos CI, Terpstra HM, Kuiper EFE, et al. FOXO1 controls protein synthesis and transcript abundance of mutant polyglutamine proteins, preventing protein aggregation. Hum Mol Genet. 2021;30(11):996\u20131005.","journal-title":"Hum Mol Genet"},{"issue":"7","key":"960_CR92","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1387\/ijdb.082819ck","volume":"53","author":"C Kappen","year":"2009","unstructured":"Kappen C, Salbaum JM. Identification of regulatory elements in the Isl1 gene locus. Int J Dev Biol. 2009;53(7):935\u201346.","journal-title":"Int J Dev Biol"},{"key":"960_CR93","doi-asserted-by":"crossref","unstructured":"Morozko EL, Smith-Geater C, Monteys AM, Pradhan S, Lim RG, Langfelder P, et al. PIAS1 modulates striatal transcription, DNA damage repair, and SUMOylation with relevance to Huntington\u2019s disease. Proc Natl Acad Sci U S A. 2021;118(4):e2021836118.","DOI":"10.1073\/pnas.2021836118"},{"issue":"27","key":"960_CR94","doi-asserted-by":"publisher","first-page":"6575","DOI":"10.1523\/JNEUROSCI.3612-16.2017","volume":"37","author":"ASC Louis Sam Titus","year":"2017","unstructured":"Louis Sam Titus ASC, Yusuff T, Cassar M, Thomas E, Kretzschmar D, D\u2019Mello SR. Reduced Expression of Foxp1 as a Contributing Factor in Huntington\u2019s Disease. J Neurosci. 2017;37(27):6575\u201387.","journal-title":"J Neurosci"},{"key":"960_CR95","doi-asserted-by":"publisher","first-page":"31022","DOI":"10.1038\/srep31022","volume":"6","author":"Y Pan","year":"2016","unstructured":"Pan Y, Daito T, Sasaki Y, Chung YH, Xing X, Pondugula S, et al. Inhibition of DNA Methyltransferases Blocks Mutant Huntingtin-Induced Neurotoxicity. Sci Rep. 2016;6:31022.","journal-title":"Sci Rep"},{"issue":"1","key":"960_CR96","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1093\/hmg\/dds403","volume":"22","author":"M Szemes","year":"2013","unstructured":"Szemes M, Dallosso AR, Melegh Z, Curry T, Li Y, Rivers C, et al. Control of epigenetic states by WT1 via regulation of de novo DNA methyltransferase 3A. Hum Mol Genet. 2013;22(1):74\u201383.","journal-title":"Hum Mol Genet"},{"key":"960_CR97","doi-asserted-by":"crossref","unstructured":"Esvald EE, M\u00f5istus A, Lehe K, Avarlaid A, Subina A, Kuusemets L, et al. Stimulus-dependent expression of Bdnf is mediated by ATF2, MYT1L, and EGR1 transcription factors. J Neurosci. 2025;45(12).","DOI":"10.1523\/JNEUROSCI.0313-24.2025"},{"key":"960_CR98","doi-asserted-by":"publisher","first-page":"155563","DOI":"10.1016\/j.metabol.2023.155563","volume":"144","author":"SR Nagarajan","year":"2023","unstructured":"Nagarajan SR, Livingstone EJ, Monfeuga T, Lewis LC, Ali SHL, Chandran A, et al. MLX plays a key role in lipid and glucose metabolism in humans: Evidence from in vitro and in vivo studies. Metabolism. 2023;144:155563.","journal-title":"Metabolism"},{"key":"960_CR99","doi-asserted-by":"crossref","unstructured":"Sneha NP, Dharshini SAP, Taguchi YH, Gromiha MM. Integrative meta-analysis of Huntington\u2019s disease transcriptome landscape. Genes (Basel). 2022;13(12):2337.","DOI":"10.3390\/genes13122385"},{"key":"960_CR100","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.brainres.2018.03.013","volume":"1705","author":"DJ Dennis","year":"2019","unstructured":"Dennis DJ, Han S, Schuurmans C. bHLH transcription factors in neural development, disease, and reprogramming. Brain Res. 2019;1705:48\u201365.","journal-title":"Brain Res"},{"issue":"7","key":"960_CR101","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.18632\/aging.101005","volume":"8","author":"S Horvath","year":"2016","unstructured":"Horvath S, Langfelder P, Kwak S, Aaronson J, Rosinski J, Vogt TF, et al. Huntington\u2019s disease accelerates epigenetic aging of human brain and disrupts DNA methylation levels. Aging. 2016;8(7):1485\u2013512.","journal-title":"Aging"},{"issue":"10","key":"960_CR102","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/0166-2236(89)90074-X","volume":"12","author":"RL Albin","year":"1989","unstructured":"Albin RL, Young AB, Penney JB. The functional anatomy of basal ganglia disorders. Trends Neurosci. 1989;12(10):366\u201375.","journal-title":"Trends Neurosci"},{"key":"960_CR103","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1146\/annurev-neuro-061010-113641","volume":"34","author":"CR Gerfen","year":"2011","unstructured":"Gerfen CR, Surmeier DJ. Modulation of striatal projection systems by dopamine. Annu Rev Neurosci. 2011;34:441\u201366.","journal-title":"Annu Rev Neurosci"},{"issue":"6653","key":"960_CR104","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1038\/39885","volume":"389","author":"CA Altar","year":"1997","unstructured":"Altar CA, Cai N, Bliven T, Juhasz M, Conner JM, Acheson AL, et al. Anterograde transport of brain-derived neurotrophic factor and its role in the brain. Nature. 1997;389(6653):856\u201360.","journal-title":"Nature"},{"issue":"1\u20132","key":"960_CR105","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S0006-8993(00)02237-X","volume":"866","author":"I Ferrer","year":"2000","unstructured":"Ferrer I, Goutan E, Marin C, Rey MJ, Ribalta T. Brain-derived neurotrophic factor in Huntington disease. Brain Res. 2000;866(1\u20132):257\u201361.","journal-title":"Brain Res"},{"issue":"5529","key":"960_CR106","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1126\/science.1059581","volume":"293","author":"C Zuccato","year":"2001","unstructured":"Zuccato C, Ciammola A, Rigamonti D, Leavitt BR, Goffredo D, Conti L, et al. Loss of huntingtin-mediated BDNF gene transcription in Huntington\u2019s disease. Science. 2001;293(5529):493\u20138.","journal-title":"Science"},{"issue":"3","key":"960_CR107","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1111\/j.1460-9568.2006.04590.x","volume":"23","author":"S Gines","year":"2006","unstructured":"Gines S, Bosch M, Marco S, Gavalda N, Diaz-Hernandez M, Lucas JJ, et al. Reduced expression of the TrkB receptor in Huntington\u2019s disease mouse models and in human brain. Eur J Neurosci. 2006;23(3):649\u201358.","journal-title":"Eur J Neurosci"},{"issue":"3","key":"960_CR108","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1523\/JNEUROSCI.23-03-00961.2003","volume":"23","author":"C Cepeda","year":"2003","unstructured":"Cepeda C, Hurst RS, Calvert CR, Hernandez-Echeagaray E, Nguyen OK, Jocoy E, et al. Transient and progressive electrophysiological alterations in the corticostriatal pathway in a mouse model of Huntington\u2019s disease. J Neurosci. 2003;23(3):961\u20139.","journal-title":"J Neurosci"},{"issue":"7","key":"960_CR109","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1038\/mp.2015.137","volume":"21","author":"OS Cohen","year":"2016","unstructured":"Cohen OS, Weickert TW, Hess JL, Paish LM, McCoy SY, Rothmond DA, et al. A splicing-regulatory polymorphism in DRD2 disrupts ZRANB2 binding, impairs cognitive functioning and increases risk for schizophrenia in six Han Chinese samples. Mol Psychiatry. 2016;21(7):975\u201382.","journal-title":"Mol Psychiatry"},{"key":"960_CR110","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.nbd.2017.04.013","volume":"103","author":"DJ Tischfield","year":"2017","unstructured":"Tischfield DJ, Saraswat DK, Furash A, Fowler SC, Fuccillo MV, Anderson SA. Loss of the neurodevelopmental gene Zswim6 alters striatal morphology and motor regulation. Neurobiol Dis. 2017;103:174\u201383.","journal-title":"Neurobiol Dis"}],"container-title":["Molecular Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13024-026-00960-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-026-00960-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-026-00960-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T01:03:32Z","timestamp":1785891812000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13024-026-00960-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,28]]},"references-count":110,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["960"],"URL":"https:\/\/doi.org\/10.1186\/s13024-026-00960-2","relation":{},"ISSN":["1750-1326"],"issn-type":[{"value":"1750-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,28]]},"assertion":[{"value":"15 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal work adhered to NIH guidelines under IACUC approved by protocols at the Children\u2019s Hospital of Philadelphia.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"B.L.D is a founder of Latus Bio; and has sponsored research or consults for Carbon Therapeutics, Latus Bio, and Seamless Ther; P.R.R. is a founder and employee of Latus Bio. The remaining authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"41"}}